Sandler Capital Management’s Integra LifeSciences IART Stock Holding History

Sandler Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-94,260	Closed	-$5.14M	–	130
2017 Q2	$5.14M	Buy	94,260 +8,900	+10%	+$425K	0.56%	71
2017 Q1	$3.6M	Buy	+85,360	New	+$3.65M	0.25%	130
2016 Q4	–	Sell	-51,962	Closed	-$2.15M	–	168
2016 Q3	$2.15M	Sell	51,962 -302,080	-85%	-$12.7M	0.26%	81
2016 Q2	$14.1M	Buy	354,042 +161,642	+84%	+$5.82M	1.86%	15
2016 Q1	$6.48M	Sell	192,400 -28,640	-13%	-$892K	0.78%	59
2015 Q4	$7.49M	Buy	221,040 +139,040	+170%	+$4.35M	0.71%	54
2015 Q3	$2.44M	Buy	+82,000	New	+$2.56M	0.28%	93

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sandler Capital Management's IART Position: Q3 2017 in Review

Sandler Capital Management sold out of Integra LifeSciences (IART) in Q3 2017, closing a stake of 94,260 shares — an estimated $5.14M sold.

Sandler Capital Management first reported a position in IART in Q3 2015 and held it in 7 quarters. The position peaked at $14.1M in Q2 2016. 213 funds tracked by Wall St. Rank hold IART as of Q3 2017.

Sandler Capital Management reported no remaining Integra LifeSciences position as of Q3 2017 after selling out during the quarter.
Sandler Capital Management sold 94,260 Integra LifeSciences shares in Q3 2017, an estimated $5.14M.
Sandler Capital Management first reported a position in Integra LifeSciences in Q3 2015 and held it in 7 quarters.
Sandler Capital Management's Integra LifeSciences position peaked at $14.1M in Q2 2016.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2017.

Based on Sandler Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.